We are live on ! Find out more
ASLN

ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN

Delisted

ASLN was delisted on the 18th of July, 2024.

Back to rankings

7 hedge funds and large institutions have $6.48M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.12% less ownership

Funds ownership: 5.01% → 4.9% (-0.12%)

22% less funds holding

Funds holding: 9 → 7 (-2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

76% less capital inflows, than outflows

Capital inflows: $47.1K | Capital outflows: $195K

Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$27.4K
2
Platinum Investment Management
Platinum Investment Management
Australia
+$19.7K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$84.2K
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$58K
3
Millennium Management
Millennium Management
New York
-$37K
4
Morgan Stanley
Morgan Stanley
New York
-$12.6K
5
UBS Group
UBS Group
Switzerland
-$3K

ASLN Hedge Fund Activity: Q3 2020 in Review

7 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q3 2020, worth a combined $6.48M — down 7.1% from $6.97M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ASLN and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $27.4K. The largest seller was Renaissance Technologies, cutting an estimated $84.2K.

  • 7 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q3 2020, down from 9 in Q2 2020.
  • Funds reported $6.48M of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q3 2020, down 7.1% quarter-over-quarter.
  • 1 fund opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q3 2020 and 3 closed out, a net change of -2 holders.
  • The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q3 2020 was Susquehanna International Group, an estimated $27.4K added.
  • The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q3 2020 was Renaissance Technologies, an estimated $84.2K sold.

Based on aggregated 13F filings for Q3 2020.